GUILLAIN-BARRE SYNDROME
Clinical trials for GUILLAIN-BARRE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new GUILLAIN-BARRE SYNDROME trials appear
Sign up with your email to follow new studies for GUILLAIN-BARRE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hopes to speed recovery from rare nerve disease
Disease control Recruiting nowThis study tests a single dose of tanruprubart (ANX005) in 30 adults and children with Guillain-Barré syndrome (GBS), a rare nerve condition that causes weakness. The goal is to see how the drug works in the body, its early effects, and its safety. Participants must have GBS symp…
Matched conditions: GUILLAIN-BARRE SYNDROME
Phase: PHASE3 • Sponsor: Annexon, Inc. • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
New trial aims to help GBS patients breathe easier without a machine
Symptom relief Recruiting nowThis study tests two types of breathing support for 70 adults with Guillain-Barré syndrome who have serious breathing trouble. One method uses a high-flow nasal cannula, and the other uses a mask that helps with both inhaling and exhaling. The main goal is to see which method hel…
Matched conditions: GUILLAIN-BARRE SYNDROME
Phase: NA • Sponsor: Assiut University • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC